Comparison of cardiovascular and metabolic profiles in lorlatinib vs. other ALK inhibitors in global network
29 August 2026 (14:15 - 15:00)
Organised by: 

About the speaker

Tainan Hospital, Tainan (Taiwan)
3 More presentations in this session

Miss T. Paul (New Orleans, US)

Doctor I. Figueroa Baez (San Juan, PR)
Access the full session
The Event
ESC Congress 2026
29 August 2026
14:15 CET
You may be interested in
Congress Session
1 September 2025

Congress Presentation
Congress Presentation


